Compare ETFs and analyze holdings overlap
Search and add ETFs. Minimum 2 for comparison.
| ETF | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Since Inception |
|---|---|---|---|---|---|---|---|---|---|
| BNKL | 15.12% | 18.37% | 31.42% | 17.46% | 86.82% | — | — | — | 39.69% (Jul 2023) |
| TDOC.U | -0.46% | -6.39% | 0.07% | — | 4.55% | 2.81% | — | — | 1.89% (Mar 2022) |
Last six full-calendar years
| ETF | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|
| BNKL | 55.26% | 29.59% | — | — | — | — |
| TDOC.U | — | — | — | — | — | — |
TWR = Time-Weighted Return (measures fund performance). MWRR = Money-Weighted Return (measures your personal return including contribution timing). Past performance does not guarantee future results.
Latest reported top holdings for each ETF
| # | Holding | Weight |
|---|---|---|
| 1 | Toronto-Dominion Bank | 21.21% |
| 2 | Royal Bank of Canada | 21.1% |
| 3 | Canadian Imperial Bank of Commerce | 21.06% |
| 4 | Bank of Montreal | 20.53% |
| 5 | National Bank of Canada | 20.45% |
| 6 | Bank of Nova Scotia | 20.13% |
| 7 | CASH | 0.25% |
| # | Holding | Weight |
|---|---|---|
| 1 | UnitedHealth Group Inc | 2.6% |
| 2 | Novo Nordisk A/S | 2.52% |
| 3 | Eli Lilly and Co | 2.35% |
| 4 | Anthem Inc | 2.23% |
| 5 | Roche Holding AG - Partcptn | 2.18% |
| 6 | Abbvie Inc | 2.1% |
| 7 | Novartis AG | 2.04% |
| 8 | Merck & Co Inc | 2.03% |
| 9 | Vertex Pharmaceuticals Inc | 2.03% |
| 10 | Bristol-Myers Squibb Co | 2.01% |
Our in-depth Canadian investing course covers ETFs, TFSAs, RRSPs, and building a portfolio you can stick with.